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Age-related diseaseThe AAA-ATPase Cdc48 (also called p97 or VCP) acts as a key regulator in proteolytic pathways, coordinating
recruitment and targeting of substrate proteins to the 26S proteasome or lysosomal degradation. However, in
contrast to the well-known function in ubiquitin-dependent cellular processes, the physiological relevance of
Cdc48 in organismic development and maintenance of protein homeostasis is less understood. Therefore,
studies on multicellular model organisms help to decipher how Cdc48-dependent proteolysis is regulated
in time and space to meet developmental requirements. Given the importance of developmental regulation
and tissue maintenance, defects in Cdc48 activity have been linked to several human pathologies including
protein aggregation diseases. Thus, addressing the underlying disease mechanisms not only contributes to
our understanding on the organism-wide function of Cdc48 but also facilitates the design of speciﬁc medical
therapies. In this review, we will portray the role of Cdc48 in the context of multicellular organisms, pointing
out its importance for developmental processes, tissue surveillance, and disease prevention. This article is part of
a Special Issue entitled: Ubiquitin–Proteasome System. Guest Editors: Thomas Sommer and Dieter H. Wolf.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Protein degradation is vital for the regulation of protein homeostasis
(proteostasis) and triggers a variety of processes including cell cycle
progression and cellular signaling. Lysosomal proteolysis mainly affects
macromolecular structures or entire organelles and depicts a rather
coarse mechanism regarding the targeted substrates, albeit dedicated
adaptor proteins can also mediate substrate speciﬁcity [1,2]. In contrast,
the ubiquitin–proteasome system (UPS) represents the major selective
proteolytic pathway in eukaryotic cells deﬁning the degradation of spe-
ciﬁc substrate proteins. For its initiation a poly-ubiquitin chain is attached
to target proteins by a catalytic cascade based on ubiquitin-activating
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rights reserved.[3]. In some cases ubiquitin chain elongation factors called E4 enzymes
are required for efﬁcient ubiquitylation [4,5]. Polyubiquitylated proteins
are then degraded within the 26S proteasome, a multicatalytic protease
complex localized both in the cytosol and the nucleus (Fig. 1) [6–8]. Of
note, protein ubiquitylation does not necessarily result in proteasomal
degradation at all times. Attachment of ubiquitin to one or multiple
sites of a substrate protein as well as the length of the ubiquitin chain
and the linkages in between ubiquitin molecules encode speciﬁcity
towards distinct cellular pathways [9]. For instance, chains linked via
the lysine 48 residue (K48) of ubiquitin represent the conventional signal
for proteasomal degradation [6]. Conversely, modiﬁcation with a single
ubiquitin molecule or K63-linked chains, primarily triggers lysosomal
degradation as well as non-proteolytic signaling pathways [10,11].
Downstream of the ubiquitylation reaction, tagged proteins are rec-
ognized by dedicated ubiquitin binding adaptors that eventually pro-
mote the delivery to the 26S proteasome [9]. A key factor involved in
substrate recruitment, processing, mobilization as well as subsequent
proteasomal transfer is Cdc48 [12], a ubiquitin-selective segregase.
Cdc48 is a highly conserved and abundant protein in all eukaryotes
(Cdc48 in yeast, CDC-48 in Caenorhabditis elegans (C. elegans), TER94
in Drosophila melanogaster, p97 or VCP in vertebrates, for simplicity re-
ferred to as Cdc48) that belongs to the ATPases associated with diverse
cellular activities (AAA+) protein family [13]. ATP hydrolysis results in
dramatic conformational changes of the homohexameric, barrel
shaped Cdc48 complex [14,15]. These dynamic rearrangements seem
to drive ubiquitin-directed disassembly of substrate complexes [16].
Thereby, Cdc48 generates mechanical forces to selectively mobilize
Fig. 1.Mechanisticmodel for the ubiquitin-selective chaperone Cdc48. Substrate proteins (blue) are earmarked by covalent attachment of ubiquitin chains by E1, E2, and E3 enzymes (yellow,
orange, red). ➊ Cdc48 hexamers (green) cooperate with dedicated cofactors (lilac) in substrate recognition and together with E3/E4 or de-ubiquitylating (DUB) enzymes in ubiquitin chain
editing.➋ The chaperone activity of Cdc48 is required to mobilize substrate proteins from binding partners (light gray) such as protein complexes, membranes, or chromatin.➌ After segre-
gation of client proteins from their binding partner, substrates are optionally transferred to the 26S proteasome (dark gray) for degradation. See text for further details and references.
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proteasomal degradation (Fig. 1) [17]. In addition, Cdc48 acts in segre-
gating proteins out of multisubunit complexes or from immobile struc-
tures without promoting subsequent proteolysis of the substrate
(Fig. 1) [18–20]. Although the exact mechanistic requirement for
Cdc48 is unclear and could even be context-speciﬁc, protein unfolding
at least partially might be a common mechanism [17,21,22].
Initially characterized biochemically [23], Cdc48 was soon linked to
the UPS [24] and implicated in the maintenance of cellular proteostasis.
Moreover, Cdc48 emerges as a pivotal regulator of lysosomal proteolysis
through autophagic and endosomal trafﬁcking (Fig. 2) [25]. Besides the
rather broad function in protein turnover, a variety of cellular pathways
[26,27] controlling cell cycle progression, transcription, DNA damage
response, endoplasmic reticulum (ER)-associated degradation (ERAD),
and mitochondria-associated degradation (MAD) are governed by
Cdc48 (Fig. 2) [26–29]. The coordination of these diverse cellular path-
ways is deﬁned by alternative cofactors forming individual Cdc48 com-
plexes (Figs. 1 and 2) [26,30,31]. Depending on their activities, Cdc48
binding partners are subdivided into substrate recruiting and substrate
processing cofactors [32]. The recruiting factors p47 and Ufd1/Npl4 com-
pose distinct Cdc48 core complexes that determine substrate speciﬁcity
and handling [33,34]. Processing factors such as E3 and E4 enzymes [4],
or de-ubiquitylating enzymes (DUBs) associate with Cdc48 to deﬁne the
topology of ubiquitin chains by chain editing on substrate proteins
(Fig. 1) [35,36].
Most of the initial research on Cdc48 functionwas conducted in vitro,
cultured cells, or in yeast. These studies deeply strengthened the under-
standing of Cdc48 on the molecular level. However, single cell studies
bear a natural limitation as developmental and tissue-speciﬁc functions
cannot be considered. Especially with respect to the complexity of
age-related diseases, studying multicellular organisms is inevitable.
Since Cdc48 is conserved from archaea to humans, it is conceivable to
take advantage of the different model organisms at hand and to address
pursuing issues concerning tissue functionality. Here, we highlight
the physiological relevance of Cdc48 activity in the development of
multicellular organisms and delineate its vital function in cellular
proteostasis mechanisms and tissue maintenance in the context of
development and aging.
2. Create: Cdc48 function in development
2.1. Proliferation and reproduction
2.1.1. Gametogenesis
In sexually breeding organisms the availability of haploid gametes
is a prerequisite for propagation of genetic information to the nextgeneration. In the course of gametogenesis DNA duplication is
followed by two consecutive rounds of chromosome segregation in
meiotic divisions I and II, respectively. After fertilization haploid
sperm and oocyte fuse and give rise to a diploid zygote generating a
new organism. To ensure reliable reproduction meiotic divisions are
tightly regulated, which involve ubiquitin-mediated protein turnover
[37]. Sasagawa and colleagues identiﬁed a critical function of Cdc48
during meiotic cell division in C. elegans [38]. In fact, complete
downregulation of cdc48 by RNAi results in the formation of one-
celled embryos arrested with aberrant chromosomes during the ﬁrst
meiotic division. Now, it was uncovered that restriction of the
C. elegans Aurora-B kinase AIR-2, to deﬁned domains between homol-
ogous chromatids is essential for chromosomal integrity and meiotic
progression [39]. The two meiotic divisions, usually occurring in
succession, appear to be executed simultaneously in the absence of
Cdc48. This defect in meiotic timing might be explained by an expan-
sion of AIR-2 activity to ectopic chromosome regions and excessive
phosphorylation of histone H3 [39] as well as other AIR-2 substrates,
which presumably causes unscheduled release of cohesion between
chromosomes.
Intriguingly, Aurora-B has initially been identiﬁed as a Cdc48 sub-
strate in mitotic chromosome segregation using Xenopus egg extracts
[18]. In this context Aurora-B is removed from chromatin late in
mitosis, promoting chromatin decondensation and reformation of
the nucleus. In yeast cells Cdc48 restricts Aurora-B/Ilp1 kinase activity
but not chromatin association implicating explicit mechanistic
differences in between species [41,48]. While a role of Cdc48 in
Aurora-B regulation is conserved in principle in yeast and human
cells [40,48], the mitotic regulation of AIR-2 in nematodes is still
controversial [18,42,43]. Surprisingly, removal of AIR-2 from mi-
totic chromatin depends on the related AAA-ATPase CDC-48.3
(AFG2 in human or Drg1 in yeast), however, it does not require
Cdc48. Drg1 ATPase activity facilitates ribosome maturation in
yeast by segregation of cytoplasmic shuttling factors from the
pre-60S particle [44,45]. The mechanistic function of CDC-48.3
and whether it is linked to ubiquitin-mediated processes have not
been revealed so far [46] and will be tempting to address in future
studies.
2.1.2. Proliferation
Originally, Cdc48 has been identiﬁed in a screen for yeast mutants
that are defective in cell cycle progression [47], which has been fur-
ther substantiated just recently [41]. Although our knowledge of
Cdc48 function is steadily increasing, its role in cell cycle regulation
remains unclear. Cell division comprises the faithful replication of
DNA and accurate distribution of sister chromatids to the daughter
Fig. 2. Cdc48 regulates cellular proteostasis pathways. Schematic representation of a eukaryotic cell and fundamental processes mediated by Cdc48. Cdc48 (green) recognizes and/
or modulates the ubiquitylation status of substrate proteins (blue) in collaboration with dedicated cofactors (lilac, orange, red, dark blue, dark green, purple). Cdc48 activity controls
the localization, activity, or protein degradation of regulatory proteins or acts in maintaining cellular proteostasis. Protein degradation is mainly achieved in cooperation with the
26S proteasome in chromatin associated processes, ERAD, and MAD. In addition, Cdc48 mediated protein degradation is also executed by autophagy and endosomal trafﬁcking.
Several cellular degradation pathways regulated by Cdc48 are characterized and the critical substrates are known: ➊ Chromatin associated processes, e.g. Cdt1, LM3BTL1;
➋ ERAD (ER-associated degradation), e.g. hedgehog C-terminus, MHCI heavy chain; ➌MAD (mitochondria-associated degradation), e.g.Mfn1/2, Mcl1; ➍ Autophagy, e.g.mitochon-
dria, ribosomes; ➎ Endosomal trafﬁcking, e.g. EGFR, transferrin; ➏ Aggregate handling, e.g. proteins containing extended polyQ stretches, aggregation prone rhodopsin. Dashed lines
indicate that nuclear substrates are not necessarily transferred to the proteasome for degradation. The presence of proteasomes in the nucleus is not indicated in the scheme. See
text for further details and references.
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ulation of mitotic events [18,40,48,49–51]. Additionally, more recent
work establishes a central function of the Cdc48Ufd1/Npl4 complex in
DNA replication [28,43,52]. Consequently, depletion of cdc48 and
the cofactors ufd1 and npl4 by RNAi causes replication fork collapse
in C. elegans embryos as well as in the proliferative germline (Fig. 3)
[43]. In addition, embryos lacking cdc48 are hypersensitive towards
treatment with the replication inhibitor hydroxyurea. In this context,
the essential replication licensing factor Cdt1 was shown to be a tar-
get of Cdc48 [52,53]. The stability of Cdt1 is tightly regulated during
S phase of the cell cycle to avoid unscheduled re-initiation of replica-
tion and chromosomal instability [54,55]. In addition to Cdt1 degra-
dation, Cdc48 is required for chromatin dissociation of Cdc45 and
the GINS complex, two factors essential for proper assembly and pro-
gression of the replication machinery [52,53]. Elegant in vitro analysis
using Xenopus egg extracts revealed that the ATPase activity of Cdc48
is indeed required for the removal of ubiquitylated Cdt1 from dam-
aged chromatin indicating the conserved requirement of Cdc48
[52,53].
As indicated above, error free replication of genetic material is
pursued to prevent the accumulation of harmful mutations. In fact,
the innovative concept of ubiquitin-mediated protein degradation di-
rectly at the chromatin coordinated by Cdc48 is retrieved in processes
that ensure faithful transmission of genomic information and genome
stability [56–60]. Unrepaired damages encountered during replica-
tion can be bypassed by specialized translesional DNA polymerases
(TLS pol) that can read through lesions due to low replicationaccuracy. Since this decreases the chance of error free replication, po-
lymerase substitutions are kept as rare and short as possible. DVC1
was recently identiﬁed by different groups as an adaptor protein for
Cdc48 that facilitates removal of TLS pol η in replication stress
induced DNA damage events, guarding genome integrity in C. elegans
and cell culture [58,61]. In the DNA double strand break response a
tightly regulated cascade of proteins orchestrates DNA repair. Cdc48
modulates protein composition at the break site by extracting K48
ubiquitylated substrates like L3MBTL1 from DNA allowing binding
of subsequent factors [56,57,62]. Consequently, in worms the absence
of one of the two cdc48 genes manifests in increased sensitivity to-
wards ionizing radiation [56]. In this context it is interesting to note
that Cdc48 binds to SUMO and mediates DNA repair in cooperation
with the SUMO-targeted ubiquitin ligase (STUbL) in yeast [59].
Upon UV-induced stalling of the yeast RNA polymerase II complex
Cdc48 is required to support fork progression during transcription.
To this end, the large subunit Rpb1 is extracted from chromatin and
presented to the proteasome in a Cdc48 dependent manner [60]. Sev-
eral roles of Cdc48 in genome maintenance have been revealed,
which depict the potent role of Cdc48 to circumvent deleterious mu-
tations. Thus, Cdc48 appears to function as a key regulator of ﬂexibil-
ity, dynamics, and composition of chromatin associated protein
complexes promoting cell cycle progression as well as adaption to
genotoxic insults (recent reviews [26,62,63]). Future studies have to
decipher to which degree these genome surveillance mechanisms
correlate with organism-wide effects on tissue functionality and
disease development.
Fig. 3. Developmental and quality control functions of Cdc48. Regulation of fundamental cellular processes and proteostasis by Cdc48 is required for ontogenesis of multicellular
organisms as well as for maintenance of tissue functionality and preservation of health. Multicellular organisms, like C. elegans, provide powerful model systems to study the
role of Cdc48 in different tissues such as muscles (green), nervous system (red), proliferative tissues like the germline (lilac), or developing embryos (blue). Moreover, responses
to environmental stresses on development, tissue integrity, and aging can be addressed efﬁciently. Thereby, genetically tractable organisms decisively contribute to reveal systemic
functions of Cdc48 and the complexity of human pathologies including IBMPFD, neurodegenerative diseases, or cancer. See text for further details and references.
208 A. Franz et al. / Biochimica et Biophysica Acta 1843 (2014) 205–2152.1.3. Reproduction
Reproduction is a task of major importance during an organism's
life. The relevance of Cdc48 in this process was ﬁrst shown in
C. elegans. Nematodes predominantly exist as self-fertilizing her-
maphrodites producing both gametes. During their development her-
maphrodites generate sperm in a short larval period before producing
oocytes in adulthood. Central for the decision between sperm or oo-
cyte production is a regulatory network controlling the activity of
the transcription factor TRA-1. Interestingly, TRA-1A levels are elevat-
ed in cdc48mutants, which leads to premature switching from sperm
to oocyte production and consequently to a reduced brood size [64].
In this process, the Cdc48Ufd1/Npl4 complex directly interacts with
the CUL-2 based E3 ligase, implicating the cooperative control of sex
determination [64]. Moreover, UBX-domain containing cofactors of
Cdc48, namely UBXN-1, UBXN-2, and UBXN-3 are collectively involved
in the regulation of TRA-1A protein levels [65], supporting the idea
that UBXN proteins provide an additional layer of substrate speciﬁcity
in the process of sperm to oocyte switching.
Comparable to the regulation of germ cell identity in C. elegans
Cdc48 determines the mating-type of Saccharomyces cerevisiae
through non-proteolytic removal of the transcriptional repressor
Mat2α from DNA, thus enforcing a switch in gene expression and
consequently cell identity [20]. Underlining transcriptional regulation
being a common pathway, Cdc48 regulates biosynthesis of unsaturat-
ed fatty acids in yeast by unconventional proteasomal processing
[66,67]. Here, activation of the membrane bound transcription factors
Spt23 and Mga2 is achieved by Cdc48-mediated cleavage and subse-
quent nuclear import [66,67]. In both cases Cdc48 cooperates with
the cofactors Ufd1/Npl4. Transcriptional regulation by Cdc48 is con-
served in vertebrates, since mammalian HIF1α, a crucial transcription
factor initiating appropriate cellular responses to insufﬁcient oxygen
supply, is inactivated by Cdc48-dependent degradation under
normoxic conditions [68]. This process involves the UBX-domain co-
factor UBXD7 which interacts directly with the CUL2/VHL E3 ligase
probably altering its ubiquitylation activity towards HIF1α [68,69].
Considering that Cdc48 is linked to transcriptional regulation in
diverse biological contexts suggests a widespread function in geneexpression. This might be especially important for rapid cellular
reprogramming, responding to developmental or environmental
triggers.
2.2. Tissue formation and speciﬁcation
2.2.1. Myosin assembly, neurogenesis, and cell type speciﬁcation
Besides the regulation of cellular processes Cdc48 holds an estab-
lished role in the development of body architecture of multicellular or-
ganisms. Accordingly, Cdc48 has been shown to control the formation
of distinct tissues and to contribute to cell type speciﬁcation. One exam-
ple of how Cdc48 contributes to tissue functionality is the organization
of striated muscles. Muscle sarcomeres are remarkably organized pro-
tein assemblies requiring proteostasis mechanisms to ensure correct
composition and maintenance of muscle function. Thus, strict compli-
ance to protein levels in muscle tissue is substantial for health and
motility of most organisms [70]. Indeed, Cdc48 plays an important role
in muscle formation and integrity through careful regulation of the
myosin-directed chaperone UNC-45 [71–73]. Consequently, loss of func-
tion as well as overexpression of unc-45 in C. elegans results in severe
defects in myosin assembly and motility [72,73]. Poly-ubiquitylation of
UNC-45 by the E3/E4 ligases CHN-1/UFD-2 (CHIP/UBE4B in humans)
is coordinated by Cdc48 [74]. Moreover, Cdc48 function in myoﬁbril
assembly is conserved among species and can thus be linked to
human myopathy (also see Section 4.1) [74–79]. Beyond elevated
UNC-45 levels, inhibition of Cdc48 function in isolated muscle cells
from mouse and subsequent transfection with dominant negative
ATPase-deﬁcient Cdc48 causes rapid growth of myotubes [75]. This
implicates that Cdc48 limits muscle growth probably by facilitating
turnover of different myoﬁbrillar proteins balancing muscular function-
ality and atrophy [75].
Aside striated muscle, Cdc48 is also important for neuronal func-
tion. Although neuronal networks mainly consist of differentiated
cells, proper development and maintenance require extensive recon-
struction and plasticity. Accordingly, formation and degeneration of
dendritic contacts, a process called pruning, as well as regulated apo-
ptosis are important mechanisms specifying the connectivity and
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ptosis and dendrite pruning have been linked to Cdc48 in Drosophila
[80]. While strong inhibition of Cdc48 results in neuronal cell death
probably due to extensive proteotoxic stress, mild down-regulation
impedes dendrite branching and developmental apoptosis. Consis-
tently, Rumpf and colleagues identiﬁed the caspase inhibitor DIAP1
as a crucial substrate of Cdc48 in neurogenesis. Although the direct
impact of DIAP1 on neuronal plasticity remains elusive, genetic ap-
proaches indicate that DIAP1 levels are indeed critical for dendrite
pruning [80]. Likewise, Cdc48 has also been linked to neurogenesis
in vertebrates promoting the formation of dendritic spines [81],
thus implicating Cdc48 in mental agility and memory formation.
Neuroﬁbromin is a critical regulator of dendritic spine formation
and was identiﬁed as a Cdc48 interactor by a proteomic approach.
Therefore, Cdc48 and neuroﬁbromin might cooperate in the
regulation of spine density by a yet unknown mechanism [81]. Since
other important regulators of synaptogenesis likely bind to Cdc48, it
might have a more widespread function in neurogenesis [82].
In addition to tissue function Cdc48 is also implicated in cell type
speciﬁcation and patterning. As such, Cdc48 contributes to ER as-
sembly and germ cell formation in Drosophila [83], which in turn
is a prerequisite for the localization of oskar mRNA, an essential me-
diator of body axis determination in the fruit ﬂy [84]. Another regu-
lator of body axis formation in Drosophila is the transcription factor
Dorsal [85], the ﬂy ortholog of NFκB in humans. Intriguingly, Cdc48
is implicated in NFκB signaling in human cells by regulating the
degradation of the NFκB inhibitor IκBα [86]. However, a direct role
of Cdc48 in pattern formation through NFκB-related pathways has
not been revealed yet. NFκB is a key mediator of inﬂammatory sig-
naling and apoptosis in human cells and could also be linked to
Cdc48 through the UBX-domain cofactor FAF1 [87,88]. However,
while a requirement for IκBα degradation suggests an activating
role of Cdc48, the cofactor FAF1 seems to counteract NFκB activation
[86–88].
In conclusion, Cdc48's function in regulating important signaling
pathways, for instance through control of NFκB or HIF1α activity, sug-
gests that it adjusts developmental processes to stress response and
contributes to retain tissue functionality.
3. Preserve: Surveillance of proteostasis and organismic health
During life time, the proteome of an organism is challenged by var-
ious exogenous and endogenous stress factors. Damaged, misfolded,
and aggregated proteins pose a major challenge to all tissues. The
degree of toxicity varies in different cell types [2,89]. Consequently,
surveillance mechanisms ensuring cellular proteostasis are essential
to maintain both cellular integrity and tissue functionality. As a key
player in proteostasis and tissue maintenance, Cdc48 provides the
link between recognition, processing, and subsequent degradation of
misfunctional proteins. Here, we discuss the relevance of protein qual-
ity control pathways that are intimately connected to Cdc48 and their
importance for aging. The aging process is accompanied with a decline
in ﬁdelity of cellular mechanisms that preserve proteostasis [90,91]. As
a consequence of impaired detoxiﬁcation protein aggregations are
thought to cause several human pathologies manifesting with progres-
sive age.
3.1. Aging and stress tolerance
Health and lifespan of an organism can be challenged by internal
and external factors like protein folding errors, mitochondrial dys-
function or exposure towards toxic insults [2,92]. Determination of
an organism's lifespan correlates with the ability to accomplish
these stressful situations through stimulation of resistance and
proteostasis mechanisms [93]. Several signaling pathways are operat-
ing in multicellular organisms to initiate appropriate responsestowards different threats [94]. Recently our laboratory identiﬁed an
intriguing link between dynamic protein ubiquitylation and de-
ubiquitylation in the regulation of C. elegans lifespan mediated via
insulin-IGF-1 signaling [35]. Surprisingly, the lifespan of C. elegans
double mutants for cdc-48.1 (one of the two Cdc48 isoforms in
C. elegans) and the associated DUB atx-3 is signiﬁcantly extended
compared to the wild-type or the single mutants. Using a UPS
model-substrate a novel link between the length or linkage-type of
ubiquitin molecules on the target protein and longevity was identi-
ﬁed. This implicates that cooperation between Cdc-48.1 and ATX-3
modiﬁes the ubiquitin chain on a relevant factor of the insulin–
IGF-1 pathway, promoting its degradation or altered activity to medi-
ate lifespan and elevated stress response. Consequently, worms are
more resistant to heat and oxidative stress [35]. Besides insulin–
IGF-1 signaling, other pathways such as target of rapamycin (TOR)
or adenosine monophosphate activated kinase (AMPK) signaling,
critically effect lifespan regulation in multicellular organisms [92].
Activated protective response mechanisms ensure proteostasis in
certain cellular compartments like the ER, mitochondria or the
lysosomes [95–97]. Intriguingly, Cdc48 only recently emerges as a
pivotal regulator of proteostasis in distinct organelles and degrada-
tion pathways that are directly linked to the aging process.
3.2. Proteostasis in ER and mitochondria
ER-associated protein degradation (ERAD) is the best described
Cdc48-dependent proteolytic pathway [98]. Besides intrinsic sub-
strates that pass the ER for posttranslational modiﬁcation and secre-
tory transport also misfolded proteins accumulate in the ER lumen
and need to be retro-translocated into the cytosol for ubiquitin-
dependent degradation. In the ERAD pathway the Cdc48 segregase
extracts client proteins out of the ER and permits their proteasomal
turnover in the cytoplasm (Fig. 2). The recruitment of Cdc48 to the
ER membrane is mediated by a group of accessory factors including
the UBX-domain protein Ubx2 (UBXD2 in humans) [99–101]. Rep8
is another Cdc48 cofactor that mediates ERAD exclusively in mouse
gonads, suggesting tissue speciﬁcity of certain Cdc48 subcomplexes
[102]. Since ERAD is intimately linked to Cdc48 activity, acute deple-
tion of Cdc48 in worms as well as in other organisms results in in-
duced expression of ER-resident chaperones like HSP-4 (Kar2p, BiP)
and renders worms hypersensitive towards ER-stress [99,103,104].
Thus, Cdc48 acts in maintaining ER homoeostasis and reducing ER
stress, which counteracts human pathologies especially those caused
by protein aggregation [105] (also see Section 3.4) [105].
An analogous mechanism comparable to ERAD links Cdc48 func-
tion to protein quality control by mitochondria-associated degrada-
tion (MAD) (Fig. 2). The concept of a proteolytic pathway that
operates at the outer mitochondrial membrane (OMM) to prevent
mitochondrial stress is supported by recent studies on the Cdc48 co-
factor Vms1 [106]. Interestingly, Vms1 contributes to the recruitment
of Cdc48 to the OMM upon stress induction, which targets defective
OMM proteins to the UPS [95,107,108]. Consequently, Vms1 is re-
quired for protection against oxidative stress and lifespan regulation
in yeast and C. elegans [95]. However, mitochondrial localization of
Cdc48 in yeast might also occur independently from Vms1 [107].
Mitofusins are Cdc48 substrates at the OMM that are critical regula-
tors of mitochondrial integrity [109,110]. Defective mitochondria
are either repaired by fusion with functional mitochondria or, if
non-repairable, removed via autophagy (mitophagy). Cdc48, collabo-
rating with the E3 ligase Parkin, regulates the degradation of
mitofusins at the OMM, therefore prohibiting fusion and in turn pro-
moting mitophagy [110]. A similarly conserved mechanism involving
Parkin and PINK1 in mitofusin turnover and mitophagy has been sug-
gested in Drosophila and mammalian cells [109,177].
In conclusion Cdc48 links proteasomal degradation to proteostasis
in the ER and mitochondria as well as mitochondrial functionality. As
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cluding Huntington's disease and Parkinson's disease, which are caus-
ally connected to imbalanced proteostasis in the ER or mitochondria,
respectively (also see Section 3.4) [105,109,110].
3.3. Lysosomal degradation by autophagy and endosomal trafﬁcking
So far we depicted proteostasis mechanisms based on the role of
Cdc48 in the UPS. However, recently Cdc48 was also linked to lysosom-
al protein degradation (Fig. 2) [1]. In fact, turnover of macromolecules
and whole organelles by autophagy is accepted as a proteolytic path-
way for substrates that cannot be handled by the proteasome. Autoph-
agy is a sophisticated cellular mechanism involving dozens of critical
proteins coordinating the biogenesis of autophagosomes and the ﬁnal
degradation of their cargo substrates in the lysosome [96,111]. Initially,
a double-layered lipid membrane, so called phagophore, is formed,
which associates with and encompasses cytosolic cargo during
autophagosome maturation. Autophagosome maturation ceases when
the engulﬁng membrane fuses, sealing the autophagic cargo in a
membranous vesicle. Eventually, the autophagosome conﬂates with
lysosomes into autolysosomes in which lysosomal proteases catalyze
cargo degradation (Fig. 2). Substrates for autophagic degradation in-
clude protein complexes, entire organelles, and pathogenic bacteria
[111]. Upon starvation, recycling of cytosolic proteins via autophagy is
thought to counteract nutrient deprivation [112]. A specialized variant
of autophagy, so called selective autophagy, utilizes dedicated adaptors
speciﬁcally recruiting cargo proteins to the forming phagophore [113].
Substrates of selective autophagy are often ubiquitylated and hence fa-
cilitate adaptor interaction [111]. Cdc48 is required for autophagosome
maturation in mice and humans since its misregulation results in the
formation of immature autophagic vesicles containing ubiquitylated
proteins [114,115]. Likewise, Cdc48 enables the degradation of ribo-
somes (ribophagy), which involves the cofactor Ufd3 in yeast [116]. In
contrast to these ubiquitin-dependent processes, the yeast Cdc48 cofac-
tor Shp1 (p47 in humans) recognizes the ubiquitin-like modiﬁer Atg8
(LC3 in humans) and mediates autophagosome biogenesis [117].
Since Atg8 is the primary mediator of autophagic vesicle formation,
Cdc48-mediated autophagosome biogenesis might also apply for
non-ubiquitylated substrates [33]. In fact, Shp1 was ﬁrst identiﬁed as a
crucial cofactor of Cdc48 in homotypic membrane fusion important for
organelle biogenesis [33]. As critical autophagic substrates of Cdc48
still await identiﬁcation one can only speculate about mechanistic
details. The Cdc48 segregase might mediate membrane localization,
extraction or oligomerization of particular factors mediating distinct
steps of autophagosome formation or maturation [111]. Furthermore,
Cdc48 could facilitate autophagosome biogenesis by membrane fusion
events [111]. Nevertheless, it will be exciting to uncover mechanistic
details as well as systemic implications of Cdc48-dependent autophagy
in the future. Of note, autophagy is clearly connected to aging and
dysfunction is linked to the emergence of various human pathologies
(see Section 4) [96,118].
In addition to autophagy of cytosolic substrates, extracellular or
plasma membrane proteins internalized by endocytosis are similarly
degraded through vesicle fusion with lysosomes (Fig. 2). As for autoph-
agy the mechanistic role of Cdc48 in the endolysosomal pathway
differs between studies. In fact, formation of endocytotic vesicles by
Clathrin has been suggested to involve Cdc48 [119]. Similar to this,
Cdc48 is required to control the oligomeric state of EEA1, a crucial me-
diator of endosomal vesicle maturation [19]. Moreover, the cofactor
UBXD1 directs Cdc48 to endolysosomal degradation of plasma mem-
brane proteins such as the epidermal growth factor receptor (EGFR)
or Caveolin by promoting vesicle maturation [120]. Endosomal trafﬁc
and autophagy share common mechanisms of vesicle maturation and
fusion with pronounced crosstalk [121–123]. This suggests that both
mechanisms converge into in single lysosome directed degradation
pathway combined by its requirement for Cdc48. With regard todevelopment and tissue formation lysosomal degradation is involved
in a variety of essential events, obtruding to address Cdc48-
dependent autophagy not only in proteostasis but also in the develop-
ing organism [124,125].3.4. Aggregate handling
Protein degradation by the proteasome and the lysosome out-
line different mechanisms that prevent extensive accumulation of
damaged proteins. Nonetheless, cells may reach a point when pro-
tein aggregation occurs. This can be provoked by mutational abnor-
malities resulting in aggregation prone proteins but also through
signiﬁcant reduction in the efﬁciency of proteostasis mechanisms,
which are usually linked to aging [126,127]. This is highlighted by
the fact that a class of human, often age-related, pathologies share
protein aggregation as a common feature [2]. A group of neuropa-
thologies affecting the central nervous system is based on the aggre-
gation of proteins containing extended poly-glutamine stretches
(polyQ proteins). Ten different polyQ diseases are described that
are speciﬁc to the affected and consequently aggregate forming
proteins, including Huntington's disease (HD) and Machado–Joseph
disease (MJD) [128]. In Drosophila, phenotypes of polyQ disease
models are comparable to human pathologies featuring a correlation
between severity of disease and length of extended polyQ chain,
gene dosage, and age progression [128]. Interestingly, Cdc48
colocalizes with aggregated proteins in HD and MJD [128,129].
In line with this observation, Cdc48 is able to suppress neuro-
degeneration and is involved in the cell death pathway, which is in-
duced by the expression of proteins containing extended polyQ
tracts [130,131]. Cdc48 localization to polyQ aggregates tempts to
speculate about a functional relevance in human neuropathology;
however, the precise role of Cdc48 in handling of protein aggregates
is unclear. First, Cdc48 activity is believed to prevent aggregate for-
mation. Dissolving activity for polyQ aggregates of a Huntingtin
fragment was reported in vitro and in worms [128]. Furthermore,
Cdc48 is supposed to promote the refolding of insoluble heat-
denatured luciferase [132,133]. A rather indirect mechanism of aggre-
gate prevention is a general Cdc48-dependent downregulation of de
novo transcription [129]. This attenuates the constant supply of new
proteins to the cellular proteome, presumably enabling aggregate
handling or clearance. In contrast, Cdc48 has been accounted for en-
hanced aggregate formation, which correlates with Cdc48 expression
levels [128]. Likewise, Cdc48 is involved in shuttling of small protein
aggregates to larger perinuclear aggresomes, where autophagy takes
place [130,131]. These controversial concepts of Cdc48 function in
protein aggregation do not necessarily need to exclude each other. Al-
though speculative, Cdc48 might coordinate aggregate handling by
proteasomal degradation with vesicle-mediated lysosomal degrada-
tion of insoluble aggregates. As polyQ-Huntingtin interferes with
ERAD by binding to the ER resident E3 ligase gp78, inducing ER stress
and apoptosis, Cdc48-dependent aggregate handling might be even
more complex [134]. Besides polyQ-linked aggregates Cdc48 associ-
ates with ubiquitylated inclusions in Alzheimer's Disease (AD) and
prion disease [135,136]. In fact, Cdc48 is a substrate of caspase-6, a
protein upregulated in AD. Cleavage of Cdc48 subsequently leads to
impairment of the UPS advancing aggregate formation [137].
Heterologous expression of pathological aggregate forming pro-
teins in multicellular model organisms largely recapitulates charac-
teristics and properties of those observed in diseased patients [2].
These model systems will help to answer exciting questions
concerning the capacity of Cdc48 in mitigating disease severity and
how this correlates with longevity. Moreover, it will be of interest
to decipher whether Cdc48 activity involves degradation by the
proteasome or whether aggregates are rather handled via autophagy
like supposed for some neurodegenerative disorders.
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4.1. IBMPFD — disease models and human pathology
Inclusion body myopathy with Paget's disease of bone and
frontotemporal dementia (IBMPFD) is a dominantly inherited human
genetic disorder manifesting in severely reduced functionality of three
post mitotic tissues: muscle, bone, and brain [138,139]. Certain charac-
teristics of the pathology develop at different age and also vary in pen-
etrance. Congruently, myopathy is the most common clinical
manifestation with 90% of patients affected. About 50% or 30% show
characteristic degeneration of bone or developing dementia, respective-
ly. Unique clinical symptoms in all three tissues are deposition of
ubiquitylated inclusions and tissue degeneration [140–142], whereas
TDP43 inclusions are exclusively found in muscle [126] and brain tis-
sues [143]. Genomic sequencing of IBMPFD patients identiﬁed a set of
point mutations in the human Cdc48 homolog VCP that cluster at the
N and D1 domain interface (here referred to as IBMPFD mutants)
[144,145]. Several IBMPFD variants affect ATPase hydrolysis [146,147]
and show altered binding of important cofactors including Ufd2, Atx3,
UBXD1, or Neuroﬁbromin [81,120,148,149]. Recently, a rare mutation
was reported to show abnormal localization to small cellular substruc-
tures instead of even distribution throughout the cytoplasm, which
has not been described for other IBMPFD mutants [150]. The available
literature on IBMPFDmutations indicates thatmolecular aberrations re-
lating to ATPase activity [148,151], cofactor binding [79,148,151] or cel-
lular pathways [74,115,150,152] can probably not be generalized.
In accordance with the essential role of Cdc48 in several eukaryotic
organisms a mouse knock-out results in embryonic lethality
[84,126,153,154]. Since a tissue speciﬁc mouse knock-out model has
not yet been established, dominant negative effects of IBMPFDmutants
are successfully used in transgenic overexpression studies
[76–78,138,155]. Different mouse models, recapitulating the human
pathology of IBMPFD, show degeneration of myoﬁbrils and neurons
that is accompanied by elevated UNC45 protein levels and NFκB signal-
ing inmuscles, formation of TDP43 positive inclusions in both tissues as
well as defects in bone structure and composition [77,155]. Muscle de-
generation by IBMPFD mutant expression is accompanied by impaired
turnover of ubiquitin conjugates and formation of ubiquitin positive in-
clusions as well as defects in endosomal trafﬁcking [78]. Furthermore,
behavioral analysis implicates an increase in anxiety and learning de-
fects upon overexpression of pathologic Cdc48 variants. A Drosophila
IBMPFD disease model also reconstitutes myopathy shown by de-
creased ﬂying ability and further manifests memory impairment
caused by progressive neurodegeneration [76]. In agreement with in-
creased ATPase activity of IBMPFD mutants [146] elevated energy con-
sumption contributes to mutant phenotypes in affected tissues of this
ﬂy model [76]. Additionally, increased ATPase activity correlates with
enhanced degeneration phenotypes in Drosophila and promotes aggre-
gate formation in corresponding cell culture models [151]. A recent
publication by Bartolome et. al. [178] suggests that the decrease in cel-
lular ATP levels is a result of mitochondrial dysfunction.
Even though different IBMPFD models are available the underly-
ing molecular mechanisms are still rather unclear. Initial ideas of
ERAD and UPS involvement in clearing ubiquitylated depositions
could not be conclusively veriﬁed [115,150,152]. Instead the focus
has been shifted towards a role of lysosomal degradation. As de-
scribed before, Cdc48 is implicated in several steps of endosomal traf-
ﬁc and autophagosome biogenesis (see Section 3.3). Consistently,
accumulation of autophagic vesicles into larger aggresomes is im-
paired in IBMPFD mutants [130]. Conversely, formation of smaller
ubiquitylated inclusions is promoted, which do not coincide with au-
tophagy markers [130]. Interestingly, Cdc48 is localized to both struc-
tures, to aggresomes in functional cells as well as to smaller inclusions
formed upon Cdc48 depletion and in IBMPFD mutants [128,130]. Fur-
thermore, mutant Cdc48 persists immobile at these structures incontrast to wild type Cdc48 which dynamically associates with aggre-
gated structures [130]. It is likely that this Cdc48-trapping renders the
protein inactive resulting in autophagic dysfunction. In fact, autopha-
gic substrates like the selective autophagy receptor p62 itself accu-
mulate in IBMPFD mutants [79] suggesting that speciﬁcally selective
autophagy might be disturbed. This is consistent with the observation
that mutants do not show defects in eliciting autophagy upon starva-
tion [115]. Latest results suggest that IBMPFD mutations disrupt
mTOR signaling in mouse muscle causing enhanced biogenesis of
autophagosomes accompanied with elevated formation of inclusions
[156,157].
The variability regarding manifestation of disease symptoms in
between particular mutations, tissues, and also among individuals
carrying the samemutation is an important point to consider. Speciﬁc
cell types may have different demands on proteostasis mechanisms
[147] causing discrete forms of clinical features upon perturbance of
homeostasis. Furthermore, with increased age autophagy might be
favored over UPS for aggregate clearance, paying tribute to the pro-
gressive accumulation of toxic protein aggregates over life time
[158], which would be in line with the described late onset of
IBMPFD symptoms. Indeed several proteins have been identiﬁed as
substrates for proteasomal and lysosomal degradation pointing to
an interplay between both proteolytic pathways (reviewed in [159]).
Regarding the vital role of Cdc48 in the maintenance of genome
integrity (see Section 2.1.2) it is worth to mention that genome insta-
bility has not been linked to IBMPFD so far. Further work is needed to
decipher substrates and relevant cofactors of Cdc48 and their poten-
tial misregulation in proteolysis contributing to the syndrome. To
this end, model organisms will be an indispensable tool to reveal mo-
lecular mechanisms and explain the heterogeneity of pathologies
among tissues and individuals.
4.2. Other pathologies related to Cdc48
IBMPFD is not the only described disease associated with genetic
alteration of the cdc48 gene. Recently amyotrophic lateral sclerosis
(ALS), a motor-neuron disease that is characterized by upper and
lower motor neuron loss and subsequent muscle atrophy (reviewed
in [160]), was linked to mutations in the cdc48 gene [161–163]. Ap-
parently, only 1–2% of familiar ALS cases have been associated with
Cdc48 [161], and less than 1% of sporadic cases [163]. Like in
IBMPFD, myopathy and TDP43 deposition are hallmarks of the disor-
der [143], suggesting impaired autophagy also in ALS. However, au-
tophagy misregulation in ALS is discussed controversially. Induction
of autophagy might be detrimental or favorable for disease progres-
sion, dependent on early or late state of disease (reviewed in [164]).
Up to date 16 different genes have been causally associated with
ALS [160]; therefore it remains elusive to which degree Cdc48 im-
pacts on disease manifestation.
As discussed before, Cdc48 is involved in many regulatory mecha-
nisms during the cell cycle [68,86] and supports genome integrity
[56–58,60,61,165], pathways which are known to be relevant for can-
cer prevention. In contrast to degenerative diseases described above,
various cancer types are marked by increased Cdc48 levels [136,166].
It has been shown that elevated protein levels correspond to cancer
formation, reoccurrence and metastasis [167–169] (reviewed in
[136,166]). The mechanistic function of Cdc48 in tumor formation is
largely unknown, though different approaches emerge. As indicated,
Cdc48 acts on NFκB signaling via IκBα which induces a cancer
promoting, anti-apoptotic effect [86,168,170]. Furthermore, Cdc48
dephosphorylation by protein tyrosine phosphatase PTPL1, a protein
important for the maintenance of the oncogenic state of a tumor
cell, was suggested to be critical for tumorigenesis [171]. Considering
the versatile involvement of Cdc48 in cellular processes that favor
tumor outgrowth, Cdc48 is a potential target for anti-cancer therapy
[170,172].
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associated with a set of disorders was further underlined by its
established association with viral infections. Here, Cdc48 is misused
by viruses to effectively attack a host but also required for antiviral
defense [173,174]. In conclusion, we are just beginning to draw con-
nections between the molecular function of Cdc48 in proteolytic
pathways and the organism wide requirements for proteostasis
mechanisms that ensure regular development and healthy aging. Fur-
ther insight will be provided by entangled research on molecular and
multicellular model systems.
5. Concluding remarks
In vitro studies and analysis of unicellular model systems have
greatly enhanced our understanding of the cellular and mechanistic
functions of Cdc48. In combination with recently established
multicellular models we now begin to unravel the physiological rele-
vance of Cdc48 in organismic development and maintenance of tissue
functionality (Fig. 3). It is becoming evident that Cdc48 is decisively
involved in a variety of fundamental cellular processes mediated by
ubiquitylation with impact on the entire organism (Figs. 2 and 3).
However, intriguing questions emerge concerning the determination
of how, when, and which substrates are regulated by Cdc48. Increas-
ing evidence also points to a cell type-speciﬁc regulation of Cdc48
adopted to respective tissue requirements. The use of multicellular
organisms is therefore of growing importance to decipher at which
timepoints critical substrates are degraded and how this is adjusted
to developmental needs. It will be of major interest to understand
the tissue-speciﬁc regulation of Cdc48 and the coordination of its
different cellular functions. A battery of substrate recruiting and
substrate processing cofactors is at hand that presumably contributes
to substrate speciﬁcity and subcellular localization of Cdc48 by
forming specialized subcomplexes with functional diversity. Never-
theless, our knowledge about tissue or development speciﬁc expres-
sion and activity of cofactors is still surprisingly small. Cdc48 itself is
posttranslationally modiﬁed, but to what extent this contributes to
Cdc48 regulation remains elusive in most cases [175]. The current
mechanistic model links Cdc48 activity exclusively to recruitment
and processing of ubiquitylated substrates. However, cofactors of
Cdc48 are also implicated in the recognition of ubiquitin-like mole-
cules including SUMO, NEDD8, or Atg8 [59,69,117,176]. Thus, it will
be interesting to investigate whether the segregase activity of Cdc48
is generally acting on ubiquitin-like modiﬁers.
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